newsfilter
← Latest News
GlobeNewswire·

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

  • Metagenomi Therapeutics (NASDAQ: MGX) announced that CEO Jian Irish will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference.
  • The event is scheduled for Thursday, September 10, 2026, at 12:45 p.m. ET in Boston, MA.
  • The presentation will be accessible on the "News & Events" page of the company's investor website.
  • Metagenomi is an in vivo genome editing firm utilizing metagenomics to develop curative genetic medicines capable of correcting mutations anywhere in the human genome.
  • The company focuses on high-value programs with defined regulatory pathways, leveraging capabilities in site-specific deletion, insertion, & correction.
  • MGX-001 is the lead program for hemophilia A, featuring a one-time treatment designed to provide durable, life-long protection from bleeding events.
  • The company is also pursuing indications for cardiometabolic diseases using the MGX-001 integration system & partnered assets.